Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Clinical trial NCT00290953 · COMPLETED

Trial details

NCT number: NCT00290953
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lung Cancer Pulmonary Neoplasms Small Cell Lung Cancer

Start date: 2002-10-01
Primary completion: 2006-03-01
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.